FutureWorld (FWDG) 10-K/A 31 May 16 2015 FY Annual report (amended) Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Mar. 31, 2015	Sep. 30, 2014
Document And Entity Information [Abstract]
Entity Registrant Name	FUTUREWORLD CORP.
Entity Central Index Key	1,273,988
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Trading Symbol	fwdg
Current Fiscal Year End Date	--03-31
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding	731,525,768
Entity Public Float		$ 1,800,000
Document Type	10-K/A
Document Period End Date	Mar. 31, 2015
Amendment Flag	true
Amendment Description	to add xbrl
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	FY

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Mar. 31, 2015	Mar. 31, 2014
Current Assets
Cash in Banks	$ 2,330	$ 2,000
Inventory	76,591
Accounts Receivable	154,206
Prepaid expenses	100
Total Current Assets	233,227	$ 2,000
Property and Equipment
Office Furniture & Equipment (Net)	3,877
Total Property and Equipment, Net of Depreciation	3,877
Other Assets
Intangible Assets	1,697
Investment in Subsidiary (Net)	92,830
Security Deposits	2,205
Total Other Assets	96,732
Total Assets	333,836	$ 2,000
Current Liabilities
Accounts Payable	30,400	6,350
Accrued Expenses	916,366	$ 1,089,530
Notes Payable	447,762
Deferred Revenue	(365,209)
Total Current Liabilities	1,029,319	$ 1,095,880
Long Term Liabilities
Loans & notes payable - Related Parties	129,247	277,338
Total Long Term Liabilities	129,247	277,338
Total Liabilities	1,158,566	1,373,218
Stockholders' Deficit
Preferred stock, $.0001 par value, 100,000,000 shares authorized, 8,000,000 and 0 shares issued and outstanding	800
Common stock, $.0001 par value, 1,900,000,000 shares authorized, 731,525,768 and 446,373,966 shares issued and outstanding	73,153	44,637
Additional Paid-in Capital	6,713,997	4,647,567
Retained deficit accumulated	(7,612,879)	(6,063,422)
Total Stockholders' Equity (Deficit)	(824,930)	(1,371,218)
Total Liabilities & Stockholders' Deficit	$ 333,836	$ 2,000

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2015	Mar. 31, 2014
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	100,000,000	100,000,000
Preferred stock, shares issued	8,000,000	0
Preferred stock, shares outstanding	8,000,000	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	1,900,000,000	1,900,000,000
Common stock, shares issued	731,525,768	446,373,966

Consolidated Statement of Opera

Consolidated Statement of Operations - USD ($)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Operating Revenues
Net Sales	$ 90,014
Cost of Goods Sold	(48,695)
Total Operating Revenue	41,319
Operating Expenses
Salaries and Benefits	431,206	$ 129,338
Professional Fees	349,908	0
Other Administrative Expenses	316,324	12,570
Total Operating Expenses	(1,097,438)	141,908
Loss from Operations	(1,056,119)	(141,908)
Other Income and (Expenses)
Interest expense	(493,338)	(14,411)
Total Other Income and (Expenses)	(493,338)	(14,411)
Net Loss For the Period	$ (1,549,457)	$ (156,319)
Average Number of Shares Outstanding
Basic (in shares)	478,562,219	429,173,367
Net Loss Per Common Share
Basic (in dollars per share)	$ 0	$ 0

Consolidated Statement of Chang

Consolidated Statement of Changes in Stockholders Deficit - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Mar. 31, 2012		$ 41,637	$ 4,620,567	$ (5,788,872)
Balance (in shares) at Mar. 31, 2012		416,373,966
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Loss for the period				(118,231)
Balance at Mar. 31, 2013		$ 41,637	4,620,567	(5,907,103)
Balance (in shares) at Mar. 31, 2013		416,373,966
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued in exchange for debt		$ 3,000	27,000		$ 30,000
Shares issued in exchange for debt (in shares)		30,000,000
Loss for the period				(156,319)	(156,319)
Balance at Mar. 31, 2014		$ 44,637	4,647,567	(6,063,422)	(1,371,218)
Balance (in shares) at Mar. 31, 2014		446,373,966
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued in exchange for debt		$ 27,583	1,350,862		1,378,445
Shares issued in exchange for debt (in shares)		275,830,007
Common stock issued Medtest		$ 500	99,500		100,000
Common stock issued Medtest (in shares)		5,000,000
Common stock issued for services		$ 432	117,068		117,500
Common stock issued for services (in shares)		4,321,795
Preferred Stock Issuance to Talari for Conversion - Amount	$ 800		499,000		499,800
Preferred Stock Issuance to Talari for Conversion (in shares)	8,000,000
Loss for the period				(1,549,457)	(1,549,457)
Balance at Mar. 31, 2015	$ 800	$ 731,526	$ 6,713,997	$ (7,612,879)	$ (824,930)
Balance (in shares) at Mar. 31, 2015	8,000,000	731,525,768

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Cash Flows From Operating Activities
Net Loss	$ (1,549,457)	$ (156,319)
Adjustments to reconcile loss from operations to net cash provided by operating activities:
Depreciation & amortization	7,298
Amortization for Debt Discount	365,209
Changes in working capital components:
Accounts Receivable	(154,206)
Inventory Purchases	(76,591)
Pre-paid & Other	(2,305)
Purchase Equipment	(4,005)
Accounts payable	24,050	$ 6,350
Accrued salaries	471,998	129,338
Other accrued expenses	137,433	14,411
Net Cash Used by Operations	(780,576)	$ (6,220)
Cash Flows From Investing Activities
Increase in Intangible Properties	(1,697)
Net Cash provided by Investing Activities	(1,697)
Cash Flows from Financing Activities
Proceeds from Issuance of Notes Payable	903,630	$ 0
Related Party Loans	(121,027)	8,220
Net Cash Provided by Financing Activities	782,603	8,220
Net Increase (Decrease) in Cash	330	$ 2,000
Cash Balance, Beginning of the Year	2,000
Cash Balance, End of the Year	2,330	$ 2,000
Supplemental Disclosures on Interest and Income Taxes Paid:
Interest paid for the period	493,338
Income taxes paid for the period	$ 0
Supplemental Schedule of Non-Cash Investing and Financing Activities:
Conversion of debt into common stock		$ 30,000

Basis of Presentation, Business

Basis of Presentation, Business and Summary of Significant Accounting Policies	12 Months Ended
	Mar. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation, Business and Summary of Significant Accounting Policies	1. Basis of Presentation, Business and Summary of Significant Accounting Policies (a) Basis of Presentation The accompanying balance sheets as of March 31, 2015 and 2014, and the statements of operations, statements of cash flows, and statement of changes in stockholders' equity for the years ended March 31, 2015 and 2014 of FutureWorld Corp. have been prepared by the Company. In the opinion of management, the accompanying consolidated financial statements contain all adjustments (consisting solely of normal recurring adjustments) necessary to present fairly the financial position as of March 31, 2015 and 2014, and the results of operations and cash flows for the years ended March 31, 2015 and 2014. Our financial statements may not be comparable to companies that comply with public company effective dates. Due to our election not to opt out of the extended transition period that allows us to delay the adoption of new or revised accounting standards that have different effective dates for public and private companies until those standards apply to private companies. All amounts referenced in these Financial Statements and this Report are in US Dollars unless otherwise stated. (b) Nature of the Business, and History of the Company and its Subsidiaries The nature of the business and the history of the Company and its subsidiaries are as follows: Nature of the Business FutureWorld Corp, a Delaware corporation, is a leading provider of advanced technologies and solutions to the global cannabis industry. FutureWorld, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of cannabis related products and services, such as industrial Hemp. FutureWorld, through its subsidiaries, provides personal and professional THC and CBD test kits, pharmaceutical grade CBD oil solutions, SafeVape vaporizers, smart sensor technology, communication network, surveillance security, data analysis for smart cultivation and consultation for the industrial hemp and legal medicinal cannabis. Our wireless agricultural smart sensor networks offer precision to the agriculture, irrigation systems, and greenhouses for the global cannabis and hemp industry. FutureWorld and its subsidiaries do not grow, distribute or sell marijuana. As the only Cannabis Technology Accelerator, FutureWorld will incubate and fund leading technologies, products, and services for Cannabis industry (Industrial Hemp) for foreseeable future; bringing value to its core and its shareholders. Our current Subsidiaries include; HempTech Corp, CB Scientific, URVape, Bioceutical Sciences, and FutureLand Corp.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Basis of Presentation The financial statements include the accounts of FutureWorld Corp under the accrual basis of accounting. Management's Use of Estimates The Company adopted the provisions of Accounting Standards Codification subtopic 825-10, Financial Instruments ("ASC 825-10"). ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be used to measure fair value: Level 1 – Quoted prices in active markets for identical assets or liabilities. Level 2 – Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 – Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities. All items required to be recorded or measured on a recurring basis are based upon level 3 inputs. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement The Company recognizes its derivative liabilities as level 3 and values its derivatives using the methods discussed below. While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The primary assumptions that would significantly affect the fair values using the methods discussed are that of volatility and market price of the underlying common stock of the Company. Deferred Taxes The Company follows Accounting Standards Codification subtopic 740-10, Income Taxes ("ASC 740-10") for recording the provision for income taxes. Deferred tax assets and liabilities are computed based upon the difference between the financial statement and income tax basis of assets and liabilities using the enacted marginal tax rate applicable when the related asset or liability is expected to be realized or settled. Deferred income tax expenses or benefits are based on the changes in the asset or liability during each period. If available evidence suggests that it is more likely than not that some portion or all of the deferred tax assets will not be realized, a valuation allowance is required to reduce the deferred tax assets to the amount that is more likely than not to be realized. Future changes in such valuation allowance are included in the provision for deferred income taxes in the period of change. Deferred income taxes may arise from temporary differences resulting from income and expense items reported for financial accounting and tax purposes in different periods. Deferred taxes are classified as current or non-current, depending on the classification of assets and liabilities to which they relate. Deferred taxes arising from temporary differences that are not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse and are considered immaterial. Cash and Cash Equivalents For purposes of the Statement of Cash Flows, the Company considers highly liquid investments with an original maturity of three months or less to be cash equivalents. Accounts Receivable and Allowance for Doubtful Accounts The Company monitors outstanding receivables based on factors surrounding the credit risk of specific customers, historical trends, and other information. The allowance for doubtful accounts is estimated based on an assessment of the Company's ability to collect on customer accounts receivable. There is judgment involved with estimating the allowance for doubtful accounts and if the financial condition of the Company's customers were to deteriorate, resulting in their inability to make the required payments, the Company may be required to record additional allowances or charges against revenues. The Company writes-off accounts receivable against the allowance when it determines a balance is uncollectible and no longer actively pursues its collection. As of March 31, 2015 and 2014, based upon the review of the outstanding accounts receivable, the Company has determined that an allowance for doubtful accounts is not material. The allowance for doubtful debts is created by forming a credit balance which is deducted from the total receivables balance in the statement of financial position. This works in the same way as accumulated depreciation is deducted from the fixed asset cost account. The allowance for doubtful debts reduces the receivable balance to the amount that the entity prudently estimates to recover in the future. As of March 31, 2015, the Company has $68,033 trade receivable and $86,123 in related party receivable. Property and Equipment Property and equipment are stated at cost and depreciated using the straight-line method over their estimated useful lives of 3 to 5 years. When retired or otherwise disposed, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition, is reflected in earnings. Revenue Recognition The Company recognizes revenue when services are realized or realizable and earned less estimated future doubtful accounts. The Company considers revenue realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the services have been rendered and all required milestones achieved, (iii) the sales price is fixed or determinable, and (iv) Collectability is reasonably assured. Recent Accounting Pronouncements Since the year ended March 31, 2015 and through May 31, 2016, there were several new accounting pronouncements issued by the FASB. Each of these pronouncements, as applicable, has been or will be adopted by the Company. Management does not believe the adoption of any of these accounting pronouncements has had or will have a material impact on the Company's financial statements. Convertible Debentures If the conversion features of conventional convertible debt provides for a rate of conversion that is below market value at issuance, this feature is characterized as a beneficial conversion feature ("BCF"). A BCF is recorded by the Company as a debt discount pursuant to ASC Topic 470-20 "Debt with Conversion and Other Options." In those circumstances, the convertible debt is recorded net of the discount related to the BCF, and the Company amortizes the discount to interest expense, over the life of the debt. Stock-Based Compensation The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Fair Value of Financial Instruments Accounting Standards Codification subtopic 825-10, Financial Instruments ("ASC 825-10") requires disclosure of the fair value of certain financial instruments. The carrying value of cash and cash equivalents, accounts payable and accrued liabilities as reflected in the balance sheets, approximate fair value because of the short-term maturity of these instruments. All other significant financial assets, financial liabilities and equity instruments of the Company are either recognized or disclosed in the financial statements together with other information relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. Where practicable the fair values of financial assets and financial liabilities have been determined and disclosed; otherwise only available information pertinent to fair value has been disclosed. The Company follows Accounting Standards Codification subtopic 820-10, Fair Value Measurements and Disclosures ("ASC 820-10") and Accounting Standards Codification subtopic 825-10, Financial Instruments ("ASC 825-10"), which permits entities to choose to measure many financial instruments and certain other items at fair value. Beneficial Conversion Feature For conventional convertible debt where the rate of conversion is below market value, the Company records a "beneficial conversion feature" ("BCF") and related debt discount. When the Company records a BCF, the relative fair value of the BCF is recorded as a debt discount against the face amount of the respective debt instrument (offset to additional paid in capital) and amortized to interest expense over the life of the debt. Advertising, Marketing and Public Relations The Company follows the policy of charging the costs of advertising, marketing, and public relations to expense as incurred. Research and development costs N/A Income Taxes The Company follows Accounting Standards Codification subtopic 740-10, Income Taxes ("ASC 740-10") for recording the provision for income taxes. Deferred tax assets and liabilities are computed based upon the difference between the financial statement and income tax basis of assets and liabilities using the enacted marginal tax rate applicable when the related asset or liability is expected to be realized or settled. Deferred income tax expenses or benefits are based on the changes in the asset or liability during each period. If available evidence suggests that it is more likely than not that some portion or all of the deferred tax assets will not be realized, a valuation allowance is required to reduce the deferred tax assets to the amount that is more likely than not to be realized. Future changes in such valuation allowance are included in the provision for deferred income taxes in the period of change. Deferred income taxes may arise from temporary differences resulting from income and expense items reported for financial accounting and tax purposes in different periods. Deferred taxes are classified as current or non-current, depending on the classification of assets and liabilities to which they relate. Deferred taxes arising from temporary differences that are not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse and are considered immaterial. Net Income (loss) Per Common Share The Company computes earnings (loss) per share under Accounting Standards Codification subtopic 260-10, Earnings Per Share ("ASC 260-10"). Net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into common stock using the "treasury stock" and/or "if converted" methods as applicable. Preferred Shares Potential Dilution Factor Company's CEO, Mr. Talari, Holds 8,000,000 shares of Preferred Series A stock as of March 31, 2015, with conversion ratio of 1 Preferred to 200 Common stock. If all Preferred Series A stocks are converted, there will be a substantial increase in the outstanding common stock hence significant dilution to the common stock holders.

Going Concern

Going Concern	12 Months Ended
	Mar. 31, 2015
Liquidity Disclosure [Abstract]
Going Concern	3. Going Concern For the year ended March 31, 2015, the Company incurred a net loss of $1,549,457 and a cumulative net loss since inception of $7,612,879. As of March 31, 2015, the Company had a working capital deficit of $796,092 and $2,330 in cash with which to satisfy any future cash requirements. These conditions raise substantial doubt about the Company's ability to continue as a going concern. The Company depends upon capital derived from future financing activities such as loans from its officers and directors, subsequent offerings of its common stock or debt financing in order to operate and grow the business either directly or through its subsidiary. There can be no assurance that the Company will be successful in raising such capital. The key factors that are not in the Company's control and that may have a direct bearing on operating results. These factors include, but are not limited to, acceptance of the Company's business plan, the ability to raise capital in the future, the ability to expand its customer base, and the ability to hire key employees to grow the business. There may be other risks and circumstances that management may be unable to predict.

Property and Equipment

Property and Equipment	12 Months Ended
	Mar. 31, 2015
Property, Plant and Equipment [Abstract]
Property and Equipment	4. Property and Equipment Property and equipment as of March 31, 2015 and 2014 consists of the following: 2015 2014 Computer equipment $ 4,005 $ - Furniture and fixtures - - - Accumulated depreciation 128 - Net $ 3,877 $ -

Related Parties Transactions

Related Parties Transactions	12 Months Ended
	Mar. 31, 2015
Related Parties Transactions [Abstract]
Related Parties Transactions	5. Related Parties Transactions Mr. Talari has advanced funds to the Company at various times. On April 1, 2010 the Company issued a promissory note with an initial balance of $306,319 bearing interest at 5%. This note allows Mr. Talari to advance additional funds to the Company as needed. At March 31, 2015 and 2014, the balance due to Mr. Talari on this Promissory Note is $186,160 and $277,338 respectively, and the accrued interest thereon at March 31, 2015 and 2014 is $59,459 and $59,459 respectively. On 11/19/2014, Company issued 10,000,000 shares of Preferred Series A stock to Talari Industries LLC for a debt cancellation of $500,000. On 4/15/2015, the Company issued Talari Industries LLC 2,000,000 shares of shares of Preferred Series A stock.

Accrued Expenses

Accrued Expenses	12 Months Ended
	Mar. 31, 2015
Accrued Liabilities, Current [Abstract]
Accrued Expenses	6. Accrued Expenses Accrued expenses at March 31, 2015 and 2014 were as follows: 2015 2014 Accrued salaries $ 764,522 $ 1,030,071 Accrued interest 151,844 59,459 $ 916,366 $ 1,089,530

Related Parties Disclosures

Related Parties Disclosures	12 Months Ended
	Mar. 31, 2015
Related Party Transactions [Abstract]
Related Parties Disclosures	7. Related Parties Disclosures Office Space During the Company's initial stage, it has limited need for use of office space or equipment. The Company operates out of office space provided by the principals at an allocated cost to the Company in Saint Petersburg, Florida. Rent totaled $ 20,294 for the year ending 3-31-2015.

Commitments & Contingencies

Commitments & Contingencies	12 Months Ended
	Mar. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments & Contingencies	8. Commitments & Contingencies On or prior to 3/31/2015, the Company had employment agreements, employment offers with certain employees and non-employees of the company and they are as follows; Kevin Defant - Offer Letter – Temporary Term Product Development Manager · Salary · Compensation of $4,000 per month deferred until such time as we obtain funding or adequate revenue or it may be paid in part with available cash. All unpaid salary, if cannot be paid by cash, maybe paid in common stock of the company with the employee's request. · Salary will be adjusted to up to $50,000 annually based on milestones set by the CEO and board of directors and met by you at future date decided by the Board. Performance Bonuses (Grants): o You are eligible to receive a grant of 200,000 shares of common stock in FutureWorld Energy. Annually, for two years, on the anniversary of your start date, 100,000 of these restricted shares will be eligible to vest. o You will also be eligible to receive an option of 1,500,000 shares of common stock in FutureWorld Energy at $0.02 per share. Annually, for three years, on the anniversary of your start date, 500,000 of these restricted shares will be eligible to vest by achievement of your defined goals and objectives. None of the performance grants or options were issued since Mr. Defant started working for HempTech post 3/31/2015. Karin Rohret – Employment agreement – Signed April 1, 2013 – Four years' term Book Keeper/Accountant Compensation. 4.1 Base Salary. As compensation for Employee's services rendered hereunder, the Company shall pay to Employee a base salary at an annual rate equal to Twenty-Three Thousand Five Hundred Dollars ($23,500) or One Thousand Nine Hundred Fifty ($1,950) per month (the "Base Salary"). The Base Salary shall thereafter be increased annually at the greater of (i) ten percent (10%) or (ii) such other increase as may be approved by the Board of Directors. The Base Salary shall be payable to Employee on a monthly basis, when the Company is adequately funded, in accordance with the Company's standard policies for management personnel. Prior to funding, employee's salary shall accrue and will be paid with adequate funding. Until such time as Future World Energy, Inc. can hire Karen Rohret to come on board full-time as an employee to Future World Energy, this salary shall be .1875% of the yearly sum (30 hrs per month). Until modification of this document to begin full time employment Karen Rohret' salary will be Eight Hundred Fifty-Nine Dollars and 37 cents ($859.37) per month. 4.2 Incentive Compensation. With respect to each calendar year, or portion thereof, beginning with calendar year 2014, Employee shall be eligible to receive incentive compensation or a bonus, payable solely in the discretion of the Board of Directors. None of the performance grants or options were issued by 3/31/2015. Terry Gardner – Employment agreement – Signed July 1, 2014 – Four Years term VP of Engineering and Professional Services Base salary as compensation for the services to be rendered by Employee to the Company as provided in Section 1 and subject to the terms and conditions of Section 2, the Company agrees to pay to Employee $10,000 per month. However, until such time as the company is fully funded or the company wins a contract large enough to self-sustain, the Employee will be paid $3,000 per month with the remaining amount accrued on a monthly basis. Employee's salary will be reviewed on an annual basis at the twelve (12) month anniversary of this Agreement. a. Should the situation arise where the Company is unable to pay any portion of the cash compensation, the Employee shall have the right to request payment of unpaid salaries or a portion thereof in Shares of Company stock ("Shares") of the Company (unless there is a change in SEC rules which modifies or alters the Company's ability to issue shares for compensation). b. The Employee agrees that the settlement date for any compensation paid in shares shall be the date he requests issuance of Shares in lieu of cash compensation. The employee shall have sole discretion as to the timing to receive restricted Shares, for a portion of or the full compensation amount due. c. Should a situation arise, where there is no market for shares in HempTech whatsoever and said shares are unable to be converted to cash, the Company shall replace these unmarketable shares with cash compensation equal to the value intended. 3.2 Share Compensation. a. Employee, as part of the core team is entitled to receive a grant of 5% of the Company's issued and outstanding common shares, par value $0.001. The grants shall be issued or trued up as follows; at the end of the first year Employee shall be entitled to a total of 2.5% ownership of the Company's outstanding common stock, at the end of year 2 Employee shall be entitled to a total of 5% ownership of the Company's outstanding common stock. Upon change of Control, Merger or Acquisition, the ownership percentage shall accelerate to the 5% ownership level. None of the performance grants or options were issued since Mr. Gardner started working for HempTech post 3/31/2015. Sam Talari – Employment Agreement – Signed 1st day of January, 2012 CEO Compensation. 4.1 Base Salary. As compensation for Employee's services rendered hereunder, the Company shall pay to Employee a base salary at an annual rate equal to One Hundred and Two Thousand Dollars ($102,000) or Eight Thousand Five Hundred Dollars ($8,500) per month (the "Base Salary") when Company attains adequate funding. Henceforth until adequate funding, with company's ability, the Employee will be given a draw of about Four Thousand Dollars ($4,000) per month for services rendered against Employee's salary. The Base Salary shall thereafter be increased annually at the greater of (i) five percent (5%) or (ii) such other increase as may be approved by the Board of Directors. The Base Salary shall be payable to Employee on a monthly basis, in accordance with the Company's standard policies for management personnel. On 4/1/2015, The Compensation was amended for the Company to pay to Employee a base salary at an annual rate equal to One Hundred and Eighty Thousand Dollars ($180,000) or Fifteen Thousand Dollars ($15,000) per month (the "Base Salary"). CB Scientific cancelled agreements with certain employees terminated as of March 31, 2015. There are no contingencies or liabilities in effect post termination; Bill Short On April 24, 2014, the Company entered into a three-year Employment Agreement with Mr. Short, CB Scientific's Acting Chief Operations Officer. The Agreement is automatically extended for additional one-year periods without further action from the Company or the executive, unless notice of termination is given by either party within 90 days of the end of any periods. The Agreement provides for (a) a base salary of $3,000 per month, with a 5% increase per annum, and (b) all group insurance plans and other benefit plans and programs made available to the Company's management employees Derek Lebahn On May 15, 2014, the Company entered into a three-year Employment Agreement with Mr. Lebahn, the Company's Acting President of the CB Scientific Division. The Agreement is automatically extended for additional one-year periods without further action from the Company or the executive, unless notice of termination is given by either party within 90 days of the end of any periods. The Agreement provides for (a) a base salary of $2,000 per month, with a 5% increase per annum, and (b) all group insurance plans and other benefit plans and programs made available to the Company's management employees. Charles Steinberg On May 15, 2014, the Company entered into a three-year Employment Agreement with Mr. Steinberg, the Company's Acting Vice President of the CB Scientific Division. The Agreement is automatically extended for additional one-year periods without further action from the Company or the executive, unless notice of termination is given by either party within 90 days of the end of any periods. The Agreement provides for (a) a base salary of $2,000 per month, with a 5% increase per annum, and (b) all group insurance plans and other benefit plans and programs made available to the Company's management employees. Joseph Kelly On June 18, 2014, the Company entered into a three-year Employment Agreement with Mr. Kelly, the Company's Acting Product Development Executive for the CB Scientific Division. The Agreement is automatically extended for additional one-year periods without further action from the Company or the executive, unless notice of termination is given by either party within 90 days of the end of any periods. The Agreement provides for (a) a base salary of $1,600 per month, with a 5% increase per annum, and (b) all group insurance plans and other benefit plans and programs made available to the Company's management employees. Andrew Marlatt On June 18, 2014, the Company entered into a three-year Employment Agreement with Mr. Marlatt, the Company's Acting Product Development Executive for the CB Scientific Division. The Agreement is automatically extended for additional one-year periods without further action from the Company or the executive, unless notice of termination is given by either party within 90 days of the end of any periods. The Agreement provides for (a) a base salary of $2,000 per month, with a 5% increase per annum, and (b) all group insurance plans and other benefit plans and programs made available to the Company's management employees. Richard Buck On June 18, 2014, the Company entered into a three-year Employment Agreement with Mr. Buck, the Company's Acting Product Development Executive for the CB Scientific Division. The Agreement is automatically extended for additional one-year periods without further action from the Company or the executive, unless notice of termination is given by either party within 90 days of the end of any periods. The Agreement provides for (a) a base salary of $2,400 per month, with a 5% increase per annum, and (b) all group insurance plans and other benefit plans and programs made available to the Company's management employees.

Change in Management

Change in Management	12 Months Ended
	Mar. 31, 2015
Change In Management [Abstract]
Change in Management	10. Change in Management NONE

Income Taxes

Income Taxes	12 Months Ended
	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Income Taxes	11. Income Taxes Income tax benefit resulting from applying statutory rates in jurisdictions in which the Company is taxed (Federal and State of Florida) differs from the income tax provision (benefit) in our financial statements. The following table reflects the reconciliation for the years ended March 31, 2015 and 2014: 2015 2014 Federal at federal statutory rate (34.00)% (34.00)% State, net of federal deduction (3.30)% (3.30)% Change in valuation allowance 37.3% 37.3% Effective tax rate 0.00% 0.00% There is no current or deferred income tax expense or benefit allocated to continuing operations for the year ended March 31, 2015, or for the period July 23, 2002 (date of inception) through March 31, 2015. The Company has not recognized an income tax benefit for its operating losses generated through March 31, 2015 based on uncertainties concerning the Company's ability to generate taxable income in future periods. The tax benefit is offset by a valuation allowance established against deferred tax assets arising from operating losses and other temporary differences, the realization of which could not be considered more likely than not. In future periods, tax benefits and related deferred tax assets will be recognized when management considers realization of such amounts to be more likely than not. For income tax purposes the Company has available a net operating loss carry-forward of $7,614,142 from inception to March 31, 2015, which will expire year by year, unless used to offset future federal taxable income through 2025.

Equity

Equity	12 Months Ended
	Mar. 31, 2015
Equity [Abstract]
Equity	12. Equity The Company is authorized to issue 100,000,000 shares of preferred stock. The Company has the right to designate different series. As of March 31, 2015, we have designated 20,000,000 shares of Series A Preferred. The Series A preferred stock is convertible to common stock at 1 to 200 ratio and have 200 voting right per share. The Company is authorized to issue 1,900,000,000 shares of common stock. All common stock has one voting right per share. At March 31, 2015 there were 731,525,768 shares outstanding. Incentive Stock Option Plan On March 23, 2014, the Company adopted an amended Incentive Stock Option Plan ("Option Plan") for the benefit of its key employees, including officers and employee directors, consultants and affiliates. The Option Plan is intended to provide those persons who have substantial responsibility for the management and growth of the Company with additional incentives and an opportunity to obtain or increase their proprietary interest in the Company, encouraging them to continue in employment. The Company authorized 4,000,000 shares to be set aside under the Option Plan. As of March 31, 2015, the Company has not issued any shares under this plan.

Subsequent Events

Subsequent Events	12 Months Ended
	Mar. 31, 2015
Subsequent Events [Abstract]
Subsequent Events	13. Subsequent Events On June 03, 2015, FutureWorld Corp. ("FutureWorld") entered into a preliminary agreement for a proposed JV (the "Agreement") with American Green in the distribution of its ZaZZZ robotic dispensaries nationwide under the brand name CaNNaBoX. The partnership will be utilizing both companies' technical background and rapidly expanding relationships in the cannabis market. CaNNaBoX robotic dispensaries are secure delivery and control systems for use in licensed cannabis dispensaries and not "vending machines". Their specific design benefits public safety, governance, dispensaries, and consumers. The Company intends to work with the American Green to lay out specific marketing partnerships, setting up regional, national and international strategies designed to achieve to 1500 unit deployment. The Top Level Design for the Product and its target platform will be discussed in length in the actual JV Agreement. The Parties agree to make every effort to complete the Product according to the JV Agreement. From May 19 th , to June 22, 2015, FutureWorld ("we", "us" "our") issued an aggregate of $366,000 of convertible debt to five separate investors in private transactions (described below) exempt from registration under the Securities Act of 1933 (the "Securities Act") in reliance on exemptions provided by Regulation D and Section 4(a)(2) of the Securities Act. 1. We issued a $50,000 convertible promissory note, which note is due and payable 9 months from the issue date along with 8% interest, per annum. In lieu of cash repayment, the note is convertible into shares of our common stock, at the option of the note holder, based on the market price of our common stock. 2. We issued an $81,000 convertible debenture, which debenture is due and payable 12 months from the issue date along with 8% interest, per annum. In lieu of cash repayment, the debenture is convertible into shares of our common stock, at the option of the debenture holder, based on the market price of our common stock. 3. We issued a $60,000 convertible debenture, which debenture is due and payable 12 months from the issue date along with 8% interest, per annum. In lieu of cash repayment, the debenture is convertible into shares of our common stock, at the option of the debenture holder, based on the market price of our common stock. 4. We issued a $60,000 convertible debenture, which debenture is due and payable 12 months from the issue date along with 8% interest, per annum. In lieu of cash repayment, the debenture is convertible into shares of our common stock, at the option of the debenture holder, based on the market price of our common stock. 5. We issued an $115,000 convertible debenture, which debenture is due and payable 12 months from the issue date along with 8% interest, per annum. In lieu of cash repayment, the debenture is convertible into shares of our common stock, at the option of the debenture holder, based on the market price of our common stock. We intend to use the net proceeds (after payment of expenses and commissions) from the above transactions for general corporate purposes. The above descriptions are qualified in their entirety by actual terms of the definitive agreements evidencing the above transactions. On July 1 st , we signed a teaming agreement with SecondSun to provide SmartSense, SmartNergy and CaNNaLyTiX for a 52,000 sqf grow in California. The company has also agreed to resell Surna's products non-exclusively. More agreement may come to in the future. Purchase and Sale Agreement with Net:X America Inc. On December 10, 2015, FutureWorld Corp, a Delaware Corporation ("FWDG"), entered into a Purchase and Sale Agreement (the "PSA") with Net:X America Inc., an Oregon Corporation, located in Portland, Oregon (hereinafter referred to as "NXAM" or "Buyer"), to sell all of the assets of CB Scientific, Inc. (hereinafter referred to as "CB" or "SELLER"), which is a private Colorado Corporation, for stock. On February 10, 2016, FutureWorld Corp closed the CB Scientific Sale transaction. The Sale will be effective as of February 17, 2016 pending the completion of restructuring of NXAM due on February 16, 2016. Consideration for the sale and purchase of the Sellers Assets shall be in the form of financing commitment, shares of the Corporation as well as other items as set forth herein and as follows (collectively the "Consideration"): a. A purchase price paid for by the issuance of 57,105,263 shares of Common stock, par value $0.001, on the Closing Date (after recapitalization on February 17, 2016) to CB Scientific shareholders. All such common shares shall be received of the NXAM common shares under the requisite restriction of Rule 144 of the Securities Act. b. NXAM shall also issue to CB One share of Preferred Series A2 of NXAM with a thirty percent (30%) dividend of the yearly gross cash flow of the operations of CB. Such share shall not be sold or delivered to any party except for CB as a corporation. The rights to the dividend of revenue shall be designated by CB within thirty days of the execution of this agreement. Future revenue distribution shall be subject to separate agreement. CB will also receive thirty percent (30%) dividend of the yearly gross cash flow of any other operations, projects (Labs, schools, etc.) delivered by CB to the Company. c. CB shall with execution of this agreement be entitled to 25,000,000 shares of the common stock warrant of NXAM with the price for such warrant exercise being based on a 50% discount to the closing price of the stock on the date of execution of this agreement (post reverse capitalization). Such warrants shall be exercisable for a period of two years from the date of this agreement. The Company has agreed, subject to certain exceptions with respect to unsolicited proposals, not to initiate, facilitate, solicit, encourage (including, without limitation, by way of furnishing non-public information) or accept any inquiries regarding, or the making of any proposal or offer that constitutes, or could reasonably be expected to result in, an "acquisition proposal" or engage in, continue or otherwise participate in any discussions, communications or negotiations regarding an acquisition proposal. The Company also has agreed that its Board of Directors shall not approve or recommend, or publicly propose to approve or recommend, to the Company's shareholders any acquisition proposal or approve, authorize or permit or allow the Company to enter into any agreement, arrangement or understanding with respect to any acquisition proposal or enter into any agreement, arrangement or understanding in principle requiring the Company to abandon, terminate, or fail to consummate the transactions contemplated by, or breach any of its obligations under, the Asset Purchase Agreement. The Asset Purchase Agreement also contains representations, warranties and indemnification obligations of the parties customary for transactions similar to those contemplated by the Asset Purchase Agreement. Such representations and warranties are made solely for purposes of the Asset Purchase Agreement and, in some cases, may be subject to qualifications and limitations agreed to by the parties in connection with the negotiated terms of the Asset Purchase Agreement and may have been qualified by disclosures that were made in connection with the parties' entry into the Asset Purchase Agreement. In addition, certain representations and warranties set forth in the Asset Purchase Agreement may have been used for purposes of risk-allocation between CB and NXAM rather than establishing matters of fact. The representations and warranties contained in the Asset Purchase Agreement were made solely for the benefit of the parties thereto. Persons not party to the Asset Purchase Agreement, including, without limitation, the Company's shareholders and other investors, should not rely on the representations and warranties contained in the Asset Purchase Agreement, or any descriptions thereof, including those contained in this Current Report on Form 8-K (this "Report"), as characterizations of the actual facts or conditions applicable to CB product lines or any of the Company's other product lines or subsidiaries. On 11/19/2014, Company issued 10,000,000 shares of Preferred Series A stock to Talari Industries LLC for a debt cancellation of $500,000. On 4/15/2015, the Company issued Talari Industries LLC 2,000,000 shares of shares of Preferred Series A stock. Purchase and Exchange Agreement with Building Turbines, Inc On February 26, 2016, Shareholder (hereafter referred to as "Selling Holder" or by name) of Building Turbines, Inc. which is a publicly held Nevada Company (BLDW), entered into a purchase and exchange agreement with FutureWorld Corp. (hereafter referred to as "FWDG") a Delaware Corporation and its partially owned subsidiary HempTech Corp., (hereafter referred to as "HTC"), a Delaware Corporation, to deliver to FutureWorld and HempTech Shareholders, the certain share holdings of Building Turbines, Inc., as an exchange for such consideration as set forth in the agreement. In effect, post transaction, Building Turbines, Inc., will become HempTech Corp through change in control. On March 11, 2016, FutureWorld Corp closed the HempTech Corp-Building Turbines transaction. The transaction will be fully effective with the completion of restructuring of BLDW due when approved by FINRA. Consideration for the purchase and exchange agreement is as follows (collectively the "Consideration"): a. A purchase price paid for by the issuance of 62,500,950 shares of Common stock, par value $0.001, on the Closing Date (after recapitalization) to HempTech Corp shareholders. All such common shares shall be received of the BLDW common shares under the requisite restriction of Rule 144 of the Securities Act. b. In return for those shares of BLDW as designated, the BLDW selling holder, John Graham, shall receive, post-reverse division, an amount of common shares of the Corporation which will be equal to nine and nine tenths percent (9.9%) of the total outstanding common shares of the Corporation ("Exchanged Shares") after such reverse division occurs and the initial post-reverse issuance occurs. The amount of shares to be initially issued shall for such 9.9% of the total outstanding common shares after the reverse division shall be 6,187,594 common shares.

Summary of Significant Accoun19

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The financial statements include the accounts of FutureWorld Corp under the accrual basis of accounting.
Management's Use of Estimates	Management's Use of Estimates The Company adopted the provisions of Accounting Standards Codification subtopic 825-10, Financial Instruments ("ASC 825-10"). ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be used to measure fair value: Level 1 – Quoted prices in active markets for identical assets or liabilities. Level 2 – Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 – Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities. All items required to be recorded or measured on a recurring basis are based upon level 3 inputs. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement The Company recognizes its derivative liabilities as level 3 and values its derivatives using the methods discussed below. While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The primary assumptions that would significantly affect the fair values using the methods discussed are that of volatility and market price of the underlying common stock of the Company.
Deferred Taxes	Deferred Taxes The Company follows Accounting Standards Codification subtopic 740-10, Income Taxes ("ASC 740-10") for recording the provision for income taxes. Deferred tax assets and liabilities are computed based upon the difference between the financial statement and income tax basis of assets and liabilities using the enacted marginal tax rate applicable when the related asset or liability is expected to be realized or settled. Deferred income tax expenses or benefits are based on the changes in the asset or liability during each period. If available evidence suggests that it is more likely than not that some portion or all of the deferred tax assets will not be realized, a valuation allowance is required to reduce the deferred tax assets to the amount that is more likely than not to be realized. Future changes in such valuation allowance are included in the provision for deferred income taxes in the period of change. Deferred income taxes may arise from temporary differences resulting from income and expense items reported for financial accounting and tax purposes in different periods. Deferred taxes are classified as current or non-current, depending on the classification of assets and liabilities to which they relate. Deferred taxes arising from temporary differences that are not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse and are considered immaterial.
Cash and Cash Equivalents	Cash and Cash Equivalents For purposes of the Statement of Cash Flows, the Company considers highly liquid investments with an original maturity of three months or less to be cash equivalents.
Accounts Receivable and Allowance for Doubtful Accounts	Accounts Receivable and Allowance for Doubtful Accounts The Company monitors outstanding receivables based on factors surrounding the credit risk of specific customers, historical trends, and other information. The allowance for doubtful accounts is estimated based on an assessment of the Company's ability to collect on customer accounts receivable. There is judgment involved with estimating the allowance for doubtful accounts and if the financial condition of the Company's customers were to deteriorate, resulting in their inability to make the required payments, the Company may be required to record additional allowances or charges against revenues. The Company writes-off accounts receivable against the allowance when it determines a balance is uncollectible and no longer actively pursues its collection. As of March 31, 2015 and 2014, based upon the review of the outstanding accounts receivable, the Company has determined that an allowance for doubtful accounts is not material. The allowance for doubtful debts is created by forming a credit balance which is deducted from the total receivables balance in the statement of financial position. This works in the same way as accumulated depreciation is deducted from the fixed asset cost account. The allowance for doubtful debts reduces the receivable balance to the amount that the entity prudently estimates to recover in the future. As of March 31, 2015, the Company has $68,033 trade receivable and $86,123 in related party receivable.
Property and Equipment	Property and Equipment Property and equipment are stated at cost and depreciated using the straight-line method over their estimated useful lives of 3 to 5 years. When retired or otherwise disposed, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition, is reflected in earnings.
Revenue Recognition	Revenue Recognition The Company recognizes revenue when services are realized or realizable and earned less estimated future doubtful accounts. The Company considers revenue realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the services have been rendered and all required milestones achieved, (iii) the sales price is fixed or determinable, and (iv) Collectability is reasonably assured.
Convertible Debentures	Convertible Debentures If the conversion features of conventional convertible debt provides for a rate of conversion that is below market value at issuance, this feature is characterized as a beneficial conversion feature ("BCF"). A BCF is recorded by the Company as a debt discount pursuant to ASC Topic 470-20 "Debt with Conversion and Other Options." In those circumstances, the convertible debt is recorded net of the discount related to the BCF, and the Company amortizes the discount to interest expense, over the life of the debt.
Stock Based Compensation	Stock-Based Compensation The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Accounting Standards Codification subtopic 825-10, Financial Instruments ("ASC 825-10") requires disclosure of the fair value of certain financial instruments. The carrying value of cash and cash equivalents, accounts payable and accrued liabilities as reflected in the balance sheets, approximate fair value because of the short-term maturity of these instruments. All other significant financial assets, financial liabilities and equity instruments of the Company are either recognized or disclosed in the financial statements together with other information relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. Where practicable the fair values of financial assets and financial liabilities have been determined and disclosed; otherwise only available information pertinent to fair value has been disclosed. The Company follows Accounting Standards Codification subtopic 820-10, Fair Value Measurements and Disclosures ("ASC 820-10") and Accounting Standards Codification subtopic 825-10, Financial Instruments ("ASC 825-10"), which permits entities to choose to measure many financial instruments and certain other items at fair value.
Beneficial Conversion Feature	Beneficial Conversion Feature For conventional convertible debt where the rate of conversion is below market value, the Company records a "beneficial conversion feature" ("BCF") and related debt discount. When the Company records a BCF, the relative fair value of the BCF is recorded as a debt discount against the face amount of the respective debt instrument (offset to additional paid in capital) and amortized to interest expense over the life of the debt.
Advertising, Marketing and Public Relations	Advertising, Marketing and Public Relations The Company follows the policy of charging the costs of advertising, marketing, and public relations to expense as incurred.
Income Taxes	Income Taxes The Company follows Accounting Standards Codification subtopic 740-10, Income Taxes ("ASC 740-10") for recording the provision for income taxes. Deferred tax assets and liabilities are computed based upon the difference between the financial statement and income tax basis of assets and liabilities using the enacted marginal tax rate applicable when the related asset or liability is expected to be realized or settled. Deferred income tax expenses or benefits are based on the changes in the asset or liability during each period. If available evidence suggests that it is more likely than not that some portion or all of the deferred tax assets will not be realized, a valuation allowance is required to reduce the deferred tax assets to the amount that is more likely than not to be realized. Future changes in such valuation allowance are included in the provision for deferred income taxes in the period of change. Deferred income taxes may arise from temporary differences resulting from income and expense items reported for financial accounting and tax purposes in different periods. Deferred taxes are classified as current or non-current, depending on the classification of assets and liabilities to which they relate. Deferred taxes arising from temporary differences that are not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse and are considered immaterial.
Earnings (Loss) Per Share	Net Income (loss) Per Common Share The Company computes earnings (loss) per share under Accounting Standards Codification subtopic 260-10, Earnings Per Share ("ASC 260-10"). Net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into common stock using the "treasury stock" and/or "if converted" methods as applicable.

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Mar. 31, 2015
Property, Plant and Equipment [Abstract]
Schedule of property and equipment	Property and equipment as of March 31, 2015 and 2014 consists of the following: 2015 2014 Computer equipment $ 4,005 $ - Furniture and fixtures - - - Accumulated depreciation 128 - Net $ 3,877 $ -

Accrued Expenses (Tables)

Accrued Expenses (Tables)	12 Months Ended
	Mar. 31, 2015
Accrued Liabilities, Current [Abstract]
Schedule of accrued expenses	2015 2014 Accrued salaries $ 764,522 $ 1,030,071 Accrued interest 151,844 59,459 $ 916,366 $ 1,089,530

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Schedule of income tax rate reconciliation	2015 2014 Federal at federal statutory rate (34.00)% (34.00)% State, net of federal deduction (3.30)% (3.30)% Change in valuation allowance 37.3% 37.3% Effective tax rate 0.00% 0.00%

Summary of Significant Accoun23

Summary of Significant Accounting Policies (Detail Textuals)	12 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Depreciation method for Property and Equipment	straight-line method
Estimated useful lives for Property and Equipment	three to seven years

Going Concern (Detail Textuals)

Going Concern (Detail Textuals) - USD ($)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2013
Liquidity Disclosure [Abstract]
Net Loss	$ (1,549,457)	$ (156,319)
Cumulative net loss	(7,612,879)	(6,063,422)
Cash	2,330	$ 2,000
Working capital deficit	$ 796,092

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	Mar. 31, 2015	Mar. 31, 2014
Property, Plant and Equipment [Line Items]
Property and equipment Gross
Accumulated depreciation
Net	$ 3,877
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment Gross	$ 4,005
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property and equipment Gross

Accrued Expenses (Details)

Accrued Expenses (Details) - USD ($)	Mar. 31, 2015	Mar. 31, 2014
Accrued Liabilities, Current [Abstract]
Accrued salaries	$ 764,522	$ 1,030,071
Payroll tax liabilities
Accrued interest	$ 151,844	$ 59,459
Accrued penalties
Accrued Expenses, Total	$ 916,366	$ 1,089,530

Related Parties Transactions (D

Related Parties Transactions (Detail Textuals) - USD ($)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Apr. 01, 2010
Related Party Transaction [Line Items]
Balance due to related party	$ 129,247	$ 277,338
Preferred shares issued	499,800
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Initial balance of promissory note			$ 306,319
Balance due to related party	186,160	277,338
Accrued interest	59,459	$ 59,459
Preferred shares issued	$ 10,000,000

Related Parties Disclosures (De

Related Parties Disclosures (Detail Textuals 1)	12 Months Ended
	Mar. 31, 2015USD ($)
Related Party Transactions [Abstract]
Operating Leases, Rent Expense	$ 20,294

Income Taxes (Details)

Income Taxes (Details)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income Tax Disclosure [Abstract]
Federal at federal statutory rate	(34.00%)	(34.00%)
State, net of federal deduction	(3.30%)	(3.30%)
Change in valuation allowance	37.30%	37.30%
Effective tax rate	0.00%	0.00%

Income Taxes (Detail Textuals)

Income Taxes (Detail Textuals)	Mar. 31, 2015USD ($)
Income Tax Disclosure [Abstract]
Net operating loss carry-forward	$ 7,614,142

Equity (Detail Textuals)

Equity (Detail Textuals) - shares	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Stockholders Equity Note [Line Items]
Preferred stock, shares authorized	100,000,000	100,000,000
Preferred stock convertible to common stock, conversion ratio	1 to 200 ratio
Preferred stock voting right per share	200 voting
Common stock, shares authorized	1,900,000,000	1,900,000,000
Common stock voting right per share	one voting
Series A Preferred Stock [Member]
Stockholders Equity Note [Line Items]
Preferred stock, shares authorized	20,000,000

Equity (Detail Textuals 1)

Equity (Detail Textuals 1)	12 Months Ended
	Mar. 31, 2015shares
Incentive Stock Option Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized under Option Plan	4,000,000